BIO.B (Bio-Rad Laboratories) Net Issuance of Preferred Stock : $0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Bio-Rad Laboratories's net issuance of preferred for the three months ended in Sep. 2024 was $0 Mil. The number is 0, which means that Bio-Rad Laboratories has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Bio-Rad Laboratories's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Bio-Rad Laboratories Net Issuance of Preferred Stock Historical Data

The historical data trend for Bio-Rad Laboratories's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Net Issuance of Preferred Stock Chart

Bio-Rad Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Bio-Rad Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Bio-Rad Laboratories Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Bio-Rad Laboratories Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

BIO:USA

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.